Core 1: Pathology Core

核心 1:病理学核心

基本信息

  • 批准号:
    10005290
  • 负责人:
  • 金额:
    $ 21.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-22 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

Core 1: Pathology SUMMARY/ ABSTRACT The individual research projects comprising this Ovarian Cancer SPORE application require the procurement, processing, and analysis of histopathological material from patients with ovarian cancer and benign ovarian diseases. The research projects have needs for frozen and formalin-fixed, paraffin-embedded samples of tumor and normal tissue. The proposed Pathology Core augments the already established MD Anderson Cancer Center Gynecological Tumor Bank and the P30-sponsored MD Anderson Cancer Center Centralized Tissue Repository with supporting database and intranet access. The Core provides for tissue acquisition by experienced gynecological pathologists to assure high-quality tissues for the investigators participating in this SPORE as well as investigators of other SPOREs. The goal of the Pathology Core is to provide frozen tissue, paraffin-embedded tissue, and histopathological expertise related to the specific needs of the research projects comprising this SPORE proposal. To achieve this goal, the Pathology Core proposes the following Specific Aims: Aim 1 is to maintain a frozen and paraffin-embedded tissue repository of ovarian cancer, benign ovarian processes, and normal ovary. The primary tissue source will be operative and biopsy specimens submitted to the Department of Pathology at MD Anderson Cancer Center. Aim 2 is to provide pathological review for all clinical specimens utilized in the SPORE projects and to provide histopathological technical services as necessary. Such technical services include immunohistochemistry, in situ hybridization, creation of specific tissue microarray slides, pathological evaluation of mouse tumors, and microdissection of tissue sections. Aim 3 is to establish a blood/urine/ascites fluid repository from patients undergoing surgery for ovarian cancer and benign ovarian processes. These fluids will provide the resources for the testing of putative prognostic and diagnostic markers derived from experiments in the SPORE projects. Aim 4 is to create and maintain a relational SPORE Database for all samples collected by the Pathology Core. This SPORE Database will provide for a virtual tissue repository that can be shared electronically with all SPORE investigators.
核心1:病理摘要/摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JINSONG LIU其他文献

JINSONG LIU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JINSONG LIU', 18)}}的其他基金

Pathology Core
病理学核心
  • 批准号:
    10709234
  • 财政年份:
    2023
  • 资助金额:
    $ 21.97万
  • 项目类别:
Core 1: Pathology Core
核心 1:病理学核心
  • 批准号:
    10251112
  • 财政年份:
    2017
  • 资助金额:
    $ 21.97万
  • 项目类别:
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression
RAS 信号转导、衰老成纤维细胞和卵巢癌进展
  • 批准号:
    8053814
  • 财政年份:
    2008
  • 资助金额:
    $ 21.97万
  • 项目类别:
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression
RAS 信号转导、衰老成纤维细胞和卵巢癌进展
  • 批准号:
    7810639
  • 财政年份:
    2008
  • 资助金额:
    $ 21.97万
  • 项目类别:
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression
RAS 信号转导、衰老成纤维细胞和卵巢癌进展
  • 批准号:
    7534226
  • 财政年份:
    2008
  • 资助金额:
    $ 21.97万
  • 项目类别:
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression
RAS 信号传导、衰老成纤维细胞和卵巢癌进展
  • 批准号:
    7631233
  • 财政年份:
    2008
  • 资助金额:
    $ 21.97万
  • 项目类别:
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression
RAS 信号转导、衰老成纤维细胞和卵巢癌进展
  • 批准号:
    8240516
  • 财政年份:
    2008
  • 资助金额:
    $ 21.97万
  • 项目类别:

相似海外基金

Analyses of immune response and bacteria in cirrhotic ascites with Tm mapping method.
Tm 图谱法分析肝硬化腹水中的免疫反应和细菌。
  • 批准号:
    20K08305
  • 财政年份:
    2020
  • 资助金额:
    $ 21.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Randomized controlled trial to elucidate "would patients be weakened if ascites removed?"
随机对照试验阐明“如果腹水被清除,患者会变得虚弱吗?”
  • 批准号:
    20K16567
  • 财政年份:
    2020
  • 资助金额:
    $ 21.97万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of new immuno-cell therapy for the treatment of refractory malignant ascites and pleural effusion
开发新的免疫细胞疗法治疗难治性恶性腹水和胸腔积液
  • 批准号:
    19K09196
  • 财政年份:
    2019
  • 资助金额:
    $ 21.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Ascites proteomics reveal the mechanism of pancreatic cancer peritoneal dissemination
腹水蛋白质组学揭示胰腺癌腹膜播散机制
  • 批准号:
    19K18107
  • 财政年份:
    2019
  • 资助金额:
    $ 21.97万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A Novel Therapy for gastrointestinal cancer targeting exosome in malignant ascites
一种针对恶性腹水中外泌体的胃肠癌新疗法
  • 批准号:
    18H02882
  • 财政年份:
    2018
  • 资助金额:
    $ 21.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Peritoneal metastasis Prediction by exosome in washing ascites for gastric cancer
胃癌洗腹水中外泌体预测腹膜转移
  • 批准号:
    18K16321
  • 财政年份:
    2018
  • 资助金额:
    $ 21.97万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Label-free microfluidic enrichment of cancer cells from noncancer cells in ascites fluid
无标记微流体从腹水中的非癌细胞中富集癌细胞
  • 批准号:
    9251748
  • 财政年份:
    2016
  • 资助金额:
    $ 21.97万
  • 项目类别:
Preparation of ascites purification device for cancerous ascites and establishment of portable continuous ascites purification perfusion method
癌性腹水腹水净化装置的研制及便携式连续腹水净化灌注方法的建立
  • 批准号:
    16K01425
  • 财政年份:
    2016
  • 资助金额:
    $ 21.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Label-free microfluidic enrichment of cancer cells from noncancer cells in ascites fluid
无标记微流体从腹水中的非癌细胞中富集癌细胞
  • 批准号:
    9036692
  • 财政年份:
    2016
  • 资助金额:
    $ 21.97万
  • 项目类别:
Identifying Factors in Malignant Ascites Facilitating Gastric Adenocarcinoma Peritoneal Metastasis
确定恶性腹水促进胃腺癌腹膜转移的因素
  • 批准号:
    349961
  • 财政年份:
    2015
  • 资助金额:
    $ 21.97万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了